Anti CD19 Gene Therapy for B-cell Lymphoma
NCT07211048
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
18
Enrollment
OTHER_GOV
Sponsor class
Conditions
B-cell Lymphoma
Interventions
DRUG:
Anti-CD19 gene injection
Sponsor
Anhui Provincial Hospital